Bsx nyse.

Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion.Boston Scientific Corporation (BSX) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 55.88 -0.01 (-0.03%) As of 02:28PM EST. Market open. 1d 5d 1m 6m …Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational1 basis ...By Ben Hobson. • 07 Sept 2020. The Boston Scientific (NYSE:BSX) share price has risen by 9.94% over the past month and it’s currently trading at 41.48. For investors considering whether to buy, hold or...WebMARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.

Insider Trading Reports are indicating that there were more than several insider trading activities at BSX starting from Butcher Arthur C, who sale 8,278 shares at …RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – Research Report) on March 2 and set a price ta... RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific (BSX – ...27 Apr, 2022, 06:30 ET. MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing ...

Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) Study

Apr 24, 2023 · Boston Scientific ( NYSE: BSX) and Shockwave Medical ( NASDAQ: SWAV) traded flat in the pre-market Monday as UBS said that a potential buyout deal between the two companies was unlikely, contrary ... Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational1 basis ...Real-time Price Updates for Boston Scientific Corp (BSX-N), along with buy or sell indicators, analysis, charts, historical performance, news and moreWebNov 27, 2023 · Boston Scientific Corp. (NYSE: BSX)’s stock price has gone rise by 0.22 in comparison to its previous close of 55.43, however, the company has experienced a 1.61% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-25 that Ozempic could make some medical devices less necessary than before. If that ... Mount Lucas Management LP bought a new position in Boston Scientific Co. (NYSE:BSX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC.The ...

Market Activity. Funds + ETFs. After-Hours Quotes. Investing Lists. News + Insights. P/E & PEG Ratios. ©2021, EDGAR®Online, a division of Donnelley Financial …

Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ...

0.73%. $23.63B. Teleflex Inc. 0.65%. $10.33B. BSX | Complete Boston Scientific Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 29 Nov 2017 ... Is Boston Scientific (NYSE:BSX) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, ...Tax Effect of Unusual Items. -68,632. -149,867. -20,944. -221,670. -60,210. Get the detailed quarterly/annual income statement for Boston Scientific Corporation (BSX). Find out the revenue ...Boston Scientific (NYSE: BSX) ... BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023, compared to the last three-year average of 24x, implying that BSX stock ...This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive …Web

BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44.Nov 11, 2023 · During the last session, Boston Scientific Corp. (NYSE:BSX)’s traded shares were 7.46 million, with the beta value of the company hitting 0.77. At the end of the trading day, the stock’s price was $51.56, reflecting an intraday gain of 0.25% or $0.13. The 52-week high for the BSX share is $55.38 ... Nov 8, 2023 · BSX stock has seen extremely strong gains of 55% from levels of $35 in early January 2021 to around $55 now, vs. an increase of about 15% for the S&P 500 over this roughly 3-year period. 26 Apr, 2023, 06:30 ET. MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing ...5. Boston Scientific Corporation (NYSE: BSX) Number of Hedge Fund Holders In Q2 2023: 69. Market Capitalization: $73.9 Billion. Founded in 1979 and headquartered in Massachusetts, Boston ...Interactive Chart for Boston Scientific Corporation (BSX), analyze all the data with a huge range of indicators.

Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) Study

Dec 1, 202328 Apr, 2021, 06:30 ET. MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This ...To get a copy of GED, a person needs to download and complete Attachment H, which is the New York State High School Equivalency Diploma or Transcript; pay a fee via money order or certified check; and submit the document to the New York Sta...Boston Scientific Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BSX updated stock price target summary. Boston Scientific's (BSX) Wicked Rally Can Take the Stock 20% Higher Boston Scientific (BSX) made a new 52-week high on Tuesday. Can this advance keep going? Let's check the position of the charts and the condition of the indicators. In...Interactive Brokers. Visualize o gráfico de Boston Scientific Corporation ao vivo para acompanhar o movimento do preço de suas ações. Encontre previsões de mercado, …Company profile for Boston Scientific Corp. including key executives, insider trading, ownership, revenue and average growth rates. View detailed BSX description & address.WebApr 27, 2022 · 27 Apr, 2022, 06:30 ET. MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing ... MARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel ...Web

Boston Scientific Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BSX updated stock price target summary.

Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX 0.0% saw its stock ...

Boston Scientific (NYSE: BSX) ... BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023, compared to the last three-year average of 24x, implying that BSX stock ...Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific ...The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ... MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year period. Included within …MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ...Get Boston Scientific Corp. (BSX) share price, real-time stock quotes ... Stock Market Advance Course · Mutual Funds Advance Course · Fundamental Analysis ...Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, compared with -5% returns for the broader S&P500 index. The company reported mixed Q4 results last month, with revenue falling ...BSX stock has seen extremely strong gains of 55% from levels of $35 in early January 2021 to around $55 now, vs. an increase of about 15% for the S&P 500 over this roughly 3-year period. BSX is ...

NYSE: Boston Scientific Corp (BSX) = 55.89 USD. Provided by Alpha Vantage. Boston Scientific Corp stock (BSX) in USD. 1 BSX = 55.89 USD. 1 tháng. 6 tháng. 1 year. 5 năm. Hold over 40 currencies to convert and send money at any time. Open an account. Boston Scientific Corp stock performance at a glance.WebMARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to ...Continue navegando e encontre mais empresas. No ranking das maiores Empresas em Londrina, PR, estão: 1. LOVAT HYUNDAI LONDRINA, 2. EVAS CURSOS, 3. …The Bermuda Stock Exchange - 2022 Year-End Review. Hamilton, Bermuda — 10 February 2023 — The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., today reported its 2022 year-end results, with international debt listings and new listings of. Read more.Instagram:https://instagram. best online prop trading firmse mini sandp 500 futurebrookfield renewable partners stockbest futures to day trade During the last session, Boston Scientific Corp. (NYSE:BSX)’s traded shares were 7.16 million, with the beta value of the company hitting 0.76. At the end of the trading day, the stock’s price was $50.71, reflecting an intraday gain of 0.50% or $0.25. jp morgan chase dividendolgcx Feb 1, 2023 · Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ... Bleakley Financial Group LLC boosted its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 1.7% in the second quarter, according to its most recent Form 13F filing with the SEC.The ...Web wwe stovk 27 Apr, 2022, 06:30 ET. MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing ...Boston Scientific Corporation (BSX) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 55.88 -0.01 (-0.03%) As of 02:28PM EST. Market open. 1d 5d 1m 6m …About the company. Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.